Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-264041

Options or other derivatives

  • Director acquired 1,721 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Coleman Mark Director 2026-06-05 Grant or award · Restricted Stock Units +1,721 1,721 D: show line 1 in the form
Loading xslF345X06/ownership.xml…